CHLORAMPHENICOL PHARMACOKINETICS IN THE NEWBORN DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS RAJCHGOT, P., Prober, C., Soldin, S., GOLAS, C., GOOD, F., Harding, L., Macleod, S. 1983; 6 (5): 305-314

Abstract

We studied pharmacokinetics of chloramphenicol in 9 neonates having a mean gestational age of 31.2 +/- 1.9 weeks (mean +/- SEM). The studied dose was the final dose of treatment in 8 of these and the first dose in 2 of these. 1 neonate was studied twice. Concentrations of chloramphenicol and its 3-monosuccinate and 1-monosuccinate esters were measured in serum by high performance liquid chromatography. Apparent total body clearance of chloramphenicol correlated with postnatal age (r = 0.81, p less than 0.01). Mean apparent clearance was 1.1 ml X min-1 X kg-1. Serum concentrations of succinate esters were below assay sensitivity after 6 h postdose. Factors leading to excessive chloramphenicol concentrations (greater than 25.0 mg/l) were evaluated in another 44 newborns. Instability of the patient's clinical condition was an important cause of excessive serum concentrations during ongoing therapy.

View details for Web of Science ID A1983RH88400002

View details for PubMedID 6628162